» Articles » PMID: 11876710

Different Effects of Short-term Omeprazole, Lansoprazole or Pantoprazole on the Accuracy of the (13)C-urea Breath Test

Overview
Date 2002 Mar 6
PMID 11876710
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Proton pump inhibitors may interfere with the accuracy of the (13)C-urea breath test, but little information is available on the effect of standard doses of various proton pump inhibitors on this test.

Aim: To evaluate the effect of short-term standard doses of omeprazole, lansoprazole and pantoprazole on the accuracy of the standardized (13)C-urea breath test.

Methods: A total of 124 patients with Helicobacter pylori infection, diagnosed on the basis of gastric histology, rapid urease test and (13)C-urea breath test, were studied. These patients received omeprazole, 20 mg/day, lansoprazole, 30 mg/day, or pantoprazole, 40 mg/day, for 2 weeks according to a randomized protocol. (13)C-Urea breath test was repeated on days 4, 7 and 14 while on therapy and 7 days after proton pump inhibitor withdrawal.

Results: Of the patients receiving omeprazole and lansoprazole, 30% (12/40) and 20% (8/41), respectively, became (13)C-urea breath test negative during therapy, compared with none of the 42 patients treated with pantoprazole (P < 0.05). All the false negative (13)C-urea breath test results returned to positive within 1 week of drug withdrawal, with a mean recovery to 84.7 +/- 15.6% of baseline delta(13)CO(2).

Conclusions: Short-term omeprazole and lansoprazole interfere with the 13C-urea breath test, although a return to positive test results invariably occurs within 1 week of proton pump inhibitor withdrawal. In contrast, the accuracy of the (13)C-urea breath test does not appear to be significantly impaired by short-term pantoprazole, which therefore may not necessarily be withdrawn before this test.

Citing Articles

The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?.

Keogh R, Riches J Curr Oncol. 2022; 29(10):7355-7378.

PMID: 36290855 PMC: 9600994. DOI: 10.3390/curroncol29100578.


Influence of acotiamide on C-urea breath test for diagnosis.

Mizukami K, Katsuta M, Okamoto K, Fukuda K, Ogawa R, Kawahara Y J Clin Biochem Nutr. 2020; 67(3):332-337.

PMID: 33293776 PMC: 7705081. DOI: 10.3164/jcbn.20-17.


infection in subjects negative for high titer serum antibody.

Toyoshima O, Nishizawa T, Arita M, Kataoka Y, Sakitani K, Yoshida S World J Gastroenterol. 2018; 24(13):1419-1428.

PMID: 29632423 PMC: 5889822. DOI: 10.3748/wjg.v24.i13.1419.


Non-invasive diagnostic tests for Helicobacter pylori infection.

Best L, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B Cochrane Database Syst Rev. 2018; 3:CD012080.

PMID: 29543326 PMC: 6513531. DOI: 10.1002/14651858.CD012080.pub2.


Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the C-Urea Breath Test in Helicobacter pylori-Positive Patients.

Takimoto M, Tomita T, Yamasaki T, Fukui S, Taki M, Okugawa T Dig Dis Sci. 2017; 62(3):739-745.

PMID: 28083842 DOI: 10.1007/s10620-016-4439-0.